HLA class II expression on tumor cells and low numbers of tumor-associated macrophages predict clinical outcome in oropharyngeal cancer.
Bianca CioniEkaterina S JordanovaErik HooijbergRianne van der LindenRenee X de MenezesKatherine TanStefan WillemsJoris B W ElbersAnnegien BroeksAndries M BergmanCharlotte L ZuurJan Paul de BoerPublished in: Head & neck (2018)
\We identified new prognostic markers for patients with oropharyngeal cancer, which can be used for selecting patients that can benefit from immunotherapy.